PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | BTK ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CGI-1746 |
+++
BTK, IC50: 1.9 nM |
99% (HPLC) | |||||||||||||||||
Spebrutinib |
++++
BTK, IC50: <0.5 nM |
98+% | |||||||||||||||||
Acalabrutinib |
++
BTK, IC50: 3nM |
98% | |||||||||||||||||
CNX-774 |
+++
BTK, IC50: <1 nM |
99%+ | |||||||||||||||||
Ibrutinib |
++++
BTK, IC50: 0.5 nM |
98% | |||||||||||||||||
ONO-4059 analog |
+
BTK, IC50: 23.9 nM |
98% | |||||||||||||||||
RN486 |
++
BTK, IC50: 4 nM |
99%+ | |||||||||||||||||
(Z)-LFM-A13 |
+
BTK, Ki: 1.4 μM |
99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | PCI 29732 serves as a highly effective, orally bioavailable, and reversible inhibitor of BTK, displaying Kiapp values of 8.2 nM for BTK, 4.6 nM for Lck, and 2.5 nM for Lyn. Its inhibitory effect on Itk, another member of the Tec family kinases, is relatively modest. Moreover, PCI 29732 disrupts the activity of ABCG2 by competitively attaching to its ATP-binding site[1].[2]. |
Animal study | Additionally, by competitively binding to the ATP-binding site of ABCG2, PCI 29732 not only inhibits ABCG2's function but also boosts the anti-tumor effects of chemotherapeutic agents that are substrates of ABCG2[2].When administered at a dose of 20 mg/kg orally every three days for a total of five times, PCI 29732 significantly augments the anti-cancer performance of Topotecan in a H460/MX20 cell xenograft model in nude mice[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.46mL 2.69mL 1.35mL |
26.92mL 5.38mL 2.69mL |
CAS号 | 330786-25-9 |
分子式 | C22H21N5O |
分子量 | 371.44 |
SMILES Code | NC1=NC=NC2=C1C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NN2C5CCCC5 |
MDL No. | MFCD25976874 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|